Late-Onset Infant Group B Streptococcus Infection Associated with Maternal Consumption of Capsules Containing Dehydrated Placenta — Oregon, 2016

• Published in: MMWR. Morbidity and mortality weekly report Vol. 66; no. 25; pp. 677 - 678
• Main Authors: Buser, Genevieve L., Mató, Sayonara, Zhang, Alexia Y., Metcalf, Ben J., Beall, Bernard, Thomas, Ann R.
• Format: Journal Article
• Language: English
• Published: Atlanta Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services 30.06.2017; U.S. Center for Disease Control
• Subjects: Age; Antibiotics; Bacteremia; Cerebrospinal fluid; Colony-stimulating factor; Dehydration; Disease; Genomes; Gestation; Hospitals; Neonates; Notes from the Field; Placenta; Pregnancy; Rectum; Sepsis; Streptococcus agalactiae; Streptococcus infections; Vagina; Oregon; United States > US
• ISSN: 0149-2195; 1545-861X
• DOI: 10.15585/mmwr.mm6625a4

Buser et al talk about late-onset infant group B Streptococcus Infection associated with maternal consumption of capsules containing dehydrated placenta. In September 2016, the Oregon Health Authority was notified of a case of late-onset group B Streptococcus agalactiae (GBS) bacteremia in an infant that began 5 days after completion of treatment for early-onset GBS bacteremia. The infant was born at term following an uncomplicated pregnancy; maternal GBS vaginal/rectal screening culture at 37 weeks' gestation was negative. Shortly after birth, the infant developed signs of respiratory distress and was transferred to the neonatal intensive care unit where blood and cerebrospinal fluid (CSF) were obtained for culture; antibiotics were initiated for presumed sepsis.